Price $4.47 |
Market Cap
387.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
9.6
|
P/B
1.05
|
P/S
0.86
|
Dividend %
-
|
|
P/CF
3.4
|
P/FCF
12.0
|
Op. Cash Flow
61.6K
|
FCF
0.4
|
|
Op. Margin
6.70%
|
Net Margin
9.00%
|
ROE
11.60%
|
ROI
-6.70%
|
|
ROA
9.70%
|
EPS Growth
167.00%
|
Current Ratio
4.7
|
Debt/Equity
0.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
